QADI » Topics » Equity Compensation Plan Information

This excerpt taken from the QADI DEF 14A filed May 22, 2009.
Equity Compensation Plan Information
 
Information as of January 31, 2009 regarding equity compensation plans approved and not approved by stockholders is summarized in the following table:
 
                         
    (a)     (b)     (c)  
                Number of Securities
 
                Remaining Available
 
    Number of Securities
          for Future Issuance
 
    to be Issued
    Weighted-Average
    Under Equity
 
    Upon Exercise of
    Exercise Price of
    Compensation Plans
 
    Outstanding Options,
    Outstanding Options,
    (Excluding Securities
 
Plan Category
  Warrants and Rights     Warrants and Rights     Reflected in Column(a)  
 
Equity compensation plans approved by stockholders
    6,714,210 (1)   $ 7.99 (2)     1,087,399  
Equity compensation plans not approved by stockholders
                 
                         
Total
    6,714,210     $ 7.99       1,087,399  
                         
 
 
(1) Includes 5,967,260 shares issuable upon the exercise of outstanding stock options or shares subject to SARs and 746,950 shares issuable upon vesting of outstanding RSUs.
 
(2) The weighted-average exercise price does not include outstanding RSUs.


23


 

 
This excerpt taken from the QADI DEF 14A filed May 13, 2008.
Equity Compensation Plan Information
 
Information as of January 31, 2008 regarding equity compensation plans approved and not approved by stockholders is summarized in the following table:
 
                         
    Number of Securities
          Number of Securities
 
    to be Issued
    Weighted-Average
    Remaining Available
 
    Upon Exercise of
    Exercise Price of
    for Future Issuance
 
    Outstanding Options,
    Outstanding Options,
    Under Equity
 
Plan Category
  Warrants and Rights     Warrants and Rights     Compensation Plans  
 
Equity compensation plans approved by stockholders
    5,962,387     $ 7.5287       2,445,485  
Equity compensation plans not approved by stockholders
                 
                         
Total
    5,962,387     $ 7.5287       2,445,485  
                         
 
This excerpt taken from the QADI DEF 14A filed May 21, 2007.
Equity Compensation Plan Information
 
Information as of January 31, 2007 regarding equity compensation plans approved and not approved by stockholders is summarized in the following table:
 
                         
    Number of Securities
          Number of Securities
 
    to be Issued
    Weighted-Average
    Remaining Available
 
    Upon Exercise of
    Exercise Price of
    for Future Issuance
 
    Outstanding Options,
    Outstanding Options,
    Under Equity
 
Plan Category
  Warrants and Rights     Warrants and Rights     Compensation Plans  
 
Equity compensation plans approved by stockholders
    5,634,245     $ 7.3817       3,735,761  
Equity compensation plans not approved by stockholders
                 
                         
Total
    5,634,245     $ 7.3817       3,735,761  
                         
 
This excerpt taken from the QADI DEF 14A filed Jun 6, 2005.

Equity Compensation Plan Information

        Information as of January 31, 2005 regarding equity compensation plans approved and not approved by stockholders is summarized in the following table:

Plan Category

  Number of securities to be issued upon exercise of outstanding options, warrants and rights
  Weighted-average exercise price of outstanding options, warrants and rights
  Number of securities remaining available for future issuance under equity compensation plans
Equity compensation plans approved by stockholders   4,482,189   $ 6.53   2,212,886

Equity compensation plans not approved by stockholders

 


 

 


 

   
       
  Total   4,482,189   $ 6.53   2,212,886
   
       
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki